413 related articles for article (PubMed ID: 9188571)
1. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
Johnson JE; Schnell MJ; Buonocore L; Rose JK
J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
[TBL] [Abstract][Full Text] [Related]
2. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
3. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
4. Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles.
Schubert M; Joshi B; Blondel D; Harmison GG
J Virol; 1992 Mar; 66(3):1579-89. PubMed ID: 1310767
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
Owens RJ; Rose JK
J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
[TBL] [Abstract][Full Text] [Related]
6. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.
Boritz E; Gerlach J; Johnson JE; Rose JK
J Virol; 1999 Aug; 73(8):6937-45. PubMed ID: 10400792
[TBL] [Abstract][Full Text] [Related]
7. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins.
Buonocore L; Blight KJ; Rice CM; Rose JK
J Virol; 2002 Jul; 76(14):6865-72. PubMed ID: 12072487
[TBL] [Abstract][Full Text] [Related]
9. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D; Ramos JC; Barber GN
J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
Kahn JS; Schnell MJ; Buonocore L; Rose JK
Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
[TBL] [Abstract][Full Text] [Related]
11. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
Lagging LM; Meyer K; Owens RJ; Ray R
J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.
Rose NF; Roberts A; Buonocore L; Rose JK
J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984
[TBL] [Abstract][Full Text] [Related]
13. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.
Schnell MJ; Buonocore L; Boritz E; Ghosh HP; Chernish R; Rose JK
EMBO J; 1998 Aug; 17(5):1289-96. PubMed ID: 9482726
[TBL] [Abstract][Full Text] [Related]
14. Chimeric measles viruses with a foreign envelope.
Spielhofer P; Bächi T; Fehr T; Christiansen G; Cattaneo R; Kaelin K; Billeter MA; Naim HY
J Virol; 1998 Mar; 72(3):2150-9. PubMed ID: 9499071
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.
Kretzschmar E; Buonocore L; Schnell MJ; Rose JK
J Virol; 1997 Aug; 71(8):5982-9. PubMed ID: 9223488
[TBL] [Abstract][Full Text] [Related]
16. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
17. Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system.
Wu K; Kim GN; Kang CY
J Gen Virol; 2009 May; 90(Pt 5):1135-1140. PubMed ID: 19264597
[TBL] [Abstract][Full Text] [Related]
18. Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector.
Bresk CA; Hofer T; Wilmschen S; Krismer M; Beierfuß A; Effantin G; Weissenhorn W; Hogan MJ; Jordan APO; Gelman RS; Montefiori DC; Liao HX; Schmitz JE; Haynes BF; von Laer D; Kimpel J
Viruses; 2019 Feb; 11(2):. PubMed ID: 30769947
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
20. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
